Inactive Instrument

Sector Chart Regulus Therapeutics Inc Nasdaq

Equities

US75915K1016

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
106B
23.47B -
21.9B -
18.77B
17.85B
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW